Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Vision-Sciences, Inc. (NasdaqSC:VSCI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
9 Strathmore Road
Natick, MA 01760
Phone: (508) 650-9971
Fax: (508) 650-9976
Email: info@visionsciences.com
Employees (last reported count): 63
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 61%
·Institutional: 5% (12% of float)
(9 institutions)
·Net Inst. Buying: 22.0K shares (+1.78%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Vision-Sciences, Inc. develops, manufactures and markets products for endoscopy, the science of using an instrument, known as an endoscope, to provide minimally invasive access to areas not readily visible to the human eye. The Company operates in three reportable segments: medical, industrial, and corporate. The medical segment designs, manufactures and sells an EndoSheath System, a single-use device that slides on to the insertion tube of a flexible endoscope. The EndoSheath gives health-care providers economic advantages compared to using conventional flexible endoscopes, as utilizing the EndoSheath allows them to avoid the burdensome cleaning required of conventional endoscopes. In addition, the EndoSheath is a sterile device that provides patients with a contaminant-free procedure.
More from Market Guide: Expanded Business Description

Financial Summary
Vision-Sciences, Inc. develops, manufactures and markets products for endoscopy that have infection control advantages over conventional flexible endoscopes designed to eliminate the risk of cross-contamination to patients and health care professionals. For the fiscal year ended 3/31/01, net sales rose 2% to $7.2 million. Net loss fell 73% to $1.3 million. Results reflect higher demand by international distributors for the ENT EndoSheath, and lower equity loss on 3DV Systems Ltd.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 1,730; after tax earnings were -875. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2001 Pay

Katsumi Oneda, 63
Chairman, Pres, CEO
$109K
Lewis Pell, 58
Vice Chairman of Directors
111K
James Tracy, 52
VP of Fin.
105K
Isao Fujimoto, 53
VP Manufacturing and Engineering of the Industrial Segment
118K
Mark Landman, 47
VP Operations of the Medical Segment
103K
Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:VSCIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 7-Dec-2000
$0.563
Recent Price$1.40 
52-Week High
on 4-June-2001
$2.05 
Beta-0.49 
Daily Volume (3-month avg)12.3K
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+1.8%
52-Week Change
relative to S&P500
+36.6%
Share-Related Items
Market Capitalization$37.1M
Shares Outstanding26.5M
Float10.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.20 
Earnings (ttm)-$0.05 
Earnings (mrq)-$0.03 
Sales (ttm)$0.30 
Cash (mrq*)$0.14 
Valuation Ratios
Price/Book (mrq*)7.11 
Price/EarningsN/A 
Price/Sales (ttm)4.64 
Income Statements
Sales (ttm)$7.36M
EBITDA (ttm*)-$925.0K
Income available to common (ttm)-$1.35M
Profitability
Profit Margin (ttm)-18.4%
Operating Margin (ttm)-16.3%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-23.33%
Return on Equity (ttm)-36.82%
Financial Strength
Current Ratio (mrq*)3.44 
Debt/Equity (mrq*)0.01 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short80.0K
Percent of Float0.8%
Shares Short
(Prior Month)
78.0K
Short Ratio16.00 
Daily Volume5,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.